Although previous studies have demonstrated that BMP9 is highly capable of inducing osteogenic differentiation of mesenchymal stem cells, the molecular mechanism involved remains to be fully elucidated. In this study, we showed that BMP9 simultaneously promotes the activation of Smad1/5/8, p38 and ERK1/2 in C3H10T1/2 cells. Knockdown of Smad4 with RNA interference reduced nuclear translocation of Smad1/5/8, and disrupted BMP9-induced osteogenic differentiation. BMP9-induced osteogenic differentiation was blocked by p38 inhibitor SB203580, whereas enhanced by ERK1/2 inhibitor PD98059. SB203580 decreased BMP9-activated Smads singling, and yet PD98059 stimulated Smads singling in C3H10T1/2 cells. The effects of inhibitor were reproduced with adenovirus expressing siRNA targeted p38 and ERK1/2, respectively. Taken together, our findings revealed that Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation. Also, it is noteworthy that p38 and ERK1/2 may play opposing regulatory roles in mediating BMP9-induced osteogenic differentiation of C3H10T1/2 cells. [BMB reports 2012; 45(4): 247-252]
INTRODUCTION
Mesenchymal stem cells (MSCs) are non-hematopoietic stem cells capable of differentiating into osteoblastic, chondrogenic, myogenic, or adipogenic lineages (1). Bone morphogenetic proteins (BMPs), members of transforming growth factors β (TGFβ) superfamily, are believed to perform pivotal functions in the areas of stem cell self-renew and differentiation during development (2, 3). To date, more than twenty BMPs have been identified. Several forms of recombinant BMPs, most notably BMP2 and BMP7, have been shown to regulate osteogenic differentiation of MSCs and are now used as adjunctive therapy in the clinical setting (4, 5). However, it has been unclear whether BMP2 and BMP7 are in fact the most potent BMPs in inducing osteogenesis.
Recent studies have indicated that BMP9, one of the least studied BMPs, is a more potent inducer in promoting osteogenic differentiation of MSCs (6-9). Further expression profiling analysis has identified several important signaling mediators of BMP9 in MSCs (7). Our previous study revealed that TGFβ type I receptors ALK1 and ALK2 are essential for BMP9-induced osteoinductive activity (8). A recent study by Wu et al. elucidated that TGFβ type II receptors BMPRII and ActRII are the functional receptors necessary to transduce BMP9-induced osteogenic signaling (9). Despite these valuable discoveries, BMP9 remains as the least characterized BMPs, and the signaling mechanism through which BMP9 regulates osteogenic differentiation of MSCs is still largely unknown and warrants extensive studies. It has been well established that BMPs can initiate intracellular signaling through activation of Smads pathway. In this case, BMPs signal transduction begins with binding to heterodimeric complex of two serine/threonine kinase receptors (2, 10). These activated receptors transmit signals by phosphorylating the transcription factors Smad1, 5, and/or 8 (2). The phosphorylated Smads form a heterodimeric complex with Smad4 in the nucleus and modulate gene expression. Besides transcription factors Smads, growing evidences have implied that mitogen activated protein kinases (MAPKs) are probably involved in transmitting intracellular signaling of BMPs (2, (11) (12) (13) (14) . MAPKs are protein kinases and occupy a central position in regulation of gene expression, mitosis, metabolism, motility, survival, apoptosis, and differentiation (15). At least four subfamilies of mammalian MAPKs have been identified, including the extracellular signal-regulated kinases (ERK1/2), ERK5, the Jun amino-terminal kinases (JNKs) and the p38 MAPKs (15). However, the different MAPKs members are activated in response to different extracellular stimuli and have different downstream targets, and thus play different roles in cellular responses. Although it has been demonstrated that BMP9 is one of the most osteogenic BMPs to induce osteogenic differentiation of MSCs, little is known about the precise mechanism involved. Whether transcription factors Smads and/or MAPKs are also relevant to BMP9-induced osteogenic differentiation of MSCs are currently unclear. For these reasons, we sought to investigate the exact roles of Smads and MAPKs in BMP9-iduced osteogenesis. Our results showed that BMP9 simultaneously promotes phosphorylation/activation of Smads, p38 and ERK1/2. Moreover, activation of Smads is necessary for BMP9-induced osteogenic differentiation of C3H10T1/2 cells. What is most noteworthy, however, is that p38 and ERK1/2 http://bmbreports.org Fig. 1 . BMP9 promoted osteogenic differentiation and activated Smads, p38 and ERK1/2 in C3H10T1/2 cells. (A). C3H10 T1/2 cells were infected with Ad-BMP9 or Ad-GFP. ALP activity was quantitatively assessed at 5, 7, 9 days post infection. Data were means ± SD of there independent experiments. **P ＜ 0.01 vs GFP. (B) C3H10T1/2 cells were infected with Ad-BMP9 or Ad-GFP. Calcium deposition was assessed by Alizarin Red S staining at 21 days post infection. Magnification, 100. (C) C3H10T1/2 cells were infected with Ad-BMP9 or Ad-GFP, at 24 hours post infection, total amount and phosphorylation forms of Smad1/5/8, p38 and ERK1/2 was analyzed by western blotting. (D) Exogenous dn-ALK1, dn-ALK2, dn-BMPRII and dn-ActRII were validated by RT-PCR. (E) C3H10T1/2 cells were infected with Ad-BMP9 in the presence of dn-ALK1, dn-ALK2, dn-BMPRII and dnActRII respectively (RFP as a control), total amount and phosphorylation forms of Smad1/5/8, p38 and ERK1/2 was detected by western blotting at 24 hours post infection. act in opposition to regulate BMP9-osteogenic differentiation partly through influence on Smads signaling cascade.
RESULTS
BMP9 promoted activation of transcription factors Smad1/5/8, p38 and ERK1/2 MAPKs in C3H10T1/2 mesenchymal stem cells
In this present study, exogenous BMP9 was introduced into C3H10T1/2 cells using recombinant adenovirus assay. ALP activity and calcium deposition were selected as early osteogenic and late osteogenic marker, respectively. Consisted with our previous reports (7-9), BMP9 was found to intensively increase ALP activity and calcium deposition of C3H10T1/2 cells (Fig.  1A, B) . These results re-confirmed that BMP9 was capable of promoting osteogenic differentiation of MSCs. Next, after BMP9-treatment, the levels of phosphorylated/activated Smads, p38 and ERK1/2 were detected by western blotting. As illustrated in Fig. 1C , BMP9 simultaneously stimulated the phosphorylation/activation of transcription factors Samd1/5/8, p38 and ERK1/2 MAPKs, without affecting the total amounts of these proteins. Our recently reports have demonstrated that dominant negative (dn) mutant of TGFβ receptors ALK1, ALK2, BMPRII and ActRII, which lack the kinase domain, remarkably inhibited osteoinductive activity and signal transduction of BMP9 (8, 9). Here, when exogenous dn-ALK1, dn-ALK2, dn-BMPRII and dn-ActRII were introduced into C3H10T1/2 cells in conjunction with BMP9 (Fig. 1D) , a significant reduction in the levels of phosphorylated Smad1/5/8, p38 and ERK1/2 was observed (Fig. 1E ). These findings indicated that BMP9 was capable of effectively activating Smad1/5/8, p38 and ERK1/2 in C3H10T1/2 cells.
Smads signaling was required for BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells
It has been well demonstrated that phosphorylated /activated Smad1/5/8 form a complex with Smad4, which translocates to the nucleus to regulate target gene transcription. To ascertain whether this signaling pathway is required for BMP9-induced osteogenic differentiation of C3H10T1/2 cells, Smad4 expression was dis-
